Sign in Register

Drug class

Vitamin K

The vitamin K therapeutic drug class comprises fat-soluble naphthoquinone compounds, most commonly formulated as phytonadione (vitamin K1), that serve as essential vitamin replacements and antihemorrhagic agents. Read more about Vitamin K

100 drugs in this class 40 manufacturers

Related classes & indications

Amino Acids, ParenteralVitamins, nutrition & electrolytes · 78 prescription drugs Vitamin DVitamins, nutrition & electrolytes · 77 prescription drugs Vitamin Deficiency PreventionTop indication · 97 prescription drugs

Showing 91–99 of 100 drugs

Sort

PHYTONADIONE (phytonadione (vit K1))

VITAMIN K · HYPOPROTHROMBINEMIA ·+5

GLENMARK PHARMA

PHYTONADIONE (phytonadione (vit K1))

VITAMIN K · HYPOPROTHROMBINEMIA ·+5

CIPLA USA, INC.

PHYTONADIONE (phytonadione (vit K1))

VITAMIN K · HYPOPROTHROMBINEMIA ·+3

EXELAN PHARMACE

PHYTONADIONE (phytonadione (vit K1))

VITAMIN K · HYPOPROTHROMBINEMIA ·+5

CAPLIN STERILES

PHYTONADIONE (phytonadione (vit K1))

VITAMIN K · HYPOPROTHROMBINEMIA ·+5

FRESENIUS KABI

PHYTONADIONE (phytonadione (vit K1))

VITAMIN K · HYPOPROTHROMBINEMIA ·+5

XIROMED, LLC

PHYTONADIONE (phytonadione (vit K1))

VITAMIN K · HYPOPROTHROMBINEMIA ·+5

SAGENT PHARMACE

PHYTONADIONE (phytonadione (vit K1))

VITAMIN K · HYPOPROTHROMBINEMIA ·+5

Baxter Healthcare Company

PHYTONADIONE (phytonadione (vit K1))

VITAMIN K · HYPOPROTHROMBINEMIA ·+5

SUN PHARMACEUTI

Filter & compare in the drug finder → Opens the drug finder with Vitamin K preselected. Add indication or manufacturer filters there.

About Vitamin K.

The vitamin K therapeutic drug class comprises fat-soluble naphthoquinone compounds, most commonly formulated as phytonadione (vitamin K1), that serve as essential vitamin replacements and antihemorrhagic agents.

These agents function as critical cofactors for the hepatic gamma-glutamyl carboxylase enzyme, enabling the post-translational activation of clotting factors II (prothrombin), VII, IX, and X, as well as endogenous anticoagulant proteins.

Clinically, vitamin K is indicated to prevent and treat hemorrhagic disease of the newborn (vitamin K deficiency bleeding) and to correct hypoprothrombinemia secondary to malabsorption, nutritional deficiency, prolonged antibacterial therapy, or direct interference with vitamin K metabolism.

It additionally serves as the primary reversal agent for anticoagulant-induced coagulopathies caused by vitamin K antagonists such as warfarin.

fda.gov
The vitamin K therapeutic drug class comprises fat-soluble naphthoquinone compounds, most commonly formulated as phytonadione (vitamin K1), that serve as essential vitamin replacements and antihemorrhagic agents
nih.gov
The vitamin K therapeutic drug class comprises fat-soluble naphthoquinone compounds, most commonly formulated as phytonadione (vitamin K1), that serve as essential vitamin replacements and antihemorrhagic agents Clinically, vitamin K is indicated to prevent and treat hemorrhagic disease of the newborn (vitamin K deficiency bleeding) and to correct hypoprothrombinemia secondary to malabsorption, nutritional deficiency, prolonged antibacterial therapy, or direct interference with vitamin K metabol...
nih.gov
The vitamin K therapeutic drug class comprises fat-soluble naphthoquinone compounds, most commonly formulated as phytonadione (vitamin K1), that serve as essential vitamin replacements and antihemorrhagic agents These agents function as critical cofactors for the hepatic gamma-glutamyl carboxylase enzyme, enabling the post-translational activation of clotting factors II (prothrombin), VII, IX, and X, as well as endogenous anticoagulant proteins
fda.gov
These agents function as critical cofactors for the hepatic gamma-glutamyl carboxylase enzyme, enabling the post-translational activation of clotting factors II (prothrombin), VII, IX, and X, as well as endogenous anticoagulant proteins Clinically, vitamin K is indicated to prevent and treat hemorrhagic disease of the newborn (vitamin K deficiency bleeding) and to correct hypoprothrombinemia secondary to malabsorption, nutritional deficiency, prolonged antibacterial therapy, or direct interferen...
fda.gov
These agents function as critical cofactors for the hepatic gamma-glutamyl carboxylase enzyme, enabling the post-translational activation of clotting factors II (prothrombin), VII, IX, and X, as well as endogenous anticoagulant proteins
fda.gov
Clinically, vitamin K is indicated to prevent and treat hemorrhagic disease of the newborn (vitamin K deficiency bleeding) and to correct hypoprothrombinemia secondary to malabsorption, nutritional deficiency, prolonged antibacterial therapy, or direct interference with vitamin K metabolism It additionally serves as the primary reversal agent for anticoagulant-induced coagulopathies caused by vitamin K antagonists such as warfarin
fda.gov
It additionally serves as the primary reversal agent for anticoagulant-induced coagulopathies caused by vitamin K antagonists such as warfarin